SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: CPAMarty who wrote (743)5/4/1999 8:26:00 PM
From: tuck  Read Replies (1) | Respond to of 2515
 
Marty et al.,

Whoa! What did I miss? IMCL is a couple of years from market, they have almost 47 million in cash, milestone payments coming, even a few sales of diagnostic probes (if memory serves), and yet they want to issue more shares? What's the rationale? Or are y'all going to make me go dig it up myself? Regardless, it could be the threat of dilution that is reversing the stock's ascent for the moment.

Cheers, Tuck (still watching, but evidently not closely enough)



To: CPAMarty who wrote (743)5/4/1999 9:49:00 PM
From: Bob Swift  Read Replies (1) | Respond to of 2515
 
15 millions more ? That means it will have 39 millions altogether. Won't that dilute the shareholders ? 24.2 million shares at 19.5 = 39.2 millions at 12. Is that what is driving IMCL down ? I am trying to get in but is this a bad moment or what ?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News